BioArctic AB's Total Assets for the quarter that ended in Mar. 2026 was kr2,679 Mil.
During the past 12 months, BioArctic AB's average Total Assets Growth Rate was -51.70% per year.
During the past 3 years, the average Total Assets Growth Rate was 93.70% per year.
During the past 5 years, the average Total Assets Growth Rate was 59.00% per year.
During the past 10 years, the average Total Assets Growth Rate was 26.40% per year.
During the past 11 years, BioArctic AB's highest 3-Year average Total Assets Growth Rate was 202.00%. The lowest was -53.00%. And the median was 42.30%.
Note:
The Net Income data used here is four times the quarterly (Mar. 2026) data.
In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.
Total Assets is linked to total revenue through Asset Turnover.
BioArctic AB's Asset Turnover for the quarter that ended in Mar. 2026 is
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.
BioArctic AB Total Assets Related Terms
BioArctic AB Total Assets Historical Data
* Premium members only.
The historical data trend for BioArctic AB's Total Assets can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.
BioArctic AB's Total Assets for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BioArctic AB (LTS:0RV2) has a Total Assets of kr2,679 Mil as of Mar. 2026. The total amount of assets as recorded on a company's balance sheet. View historical data on BioArctic AB and its competitors.
Is BioArctic AB's Total Assets too high?
BioArctic AB's current Total Assets is kr2,679 Mil. Overall, BioArctic AB has a GF Score™ of 76/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does BioArctic AB's Total Assets compare to VRTX and REGN?
BioArctic AB's Total Assets of kr2,679 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Assets for a Biotechnology company?
A good Total Assets depends on the Biotechnology industry context. However, Total Assets should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Assets mean?
A high Total Assets can signal that a stock is expensive relative to its fundamentals. The total amount of assets as recorded on a company's balance sheet. View historical data on BioArctic AB and its competitors. BioArctic AB's current Total Assets is kr2,679 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is BioArctic AB stock overvalued right now?
Based on GuruFocus' analysis, BioArctic AB (LTS:0RV2) is currently considered Significantly Undervalued. The stock's GF Value™ is kr482.98, compared to a current price of kr322.90 — trading 33.1% below its estimated fair value. The current Total Assets is kr2,679 Mil. BioArctic AB's overall GF Score™ is 76/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Assets calculated?
Total Assets is calculated from a company's financial statements. For BioArctic AB (LTS:0RV2), the current Total Assets is kr2,679 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is BioArctic AB (LTS:0RV2) Overvalued in 2026?
Based on GuruFocus' analysis, BioArctic AB stock appears to be undervalued.
The current stock price of kr322.90 is trading 33.1% below its estimated GF Value™ of kr482.98.
GuruFocus considers BioArctic AB to be Significantly Undervalued.
Key valuation signals for LTS:0RV2:
Total Assets: kr2,679 Mil
GF Value™: kr482.98 vs. price of kr322.90 (33.1% below fair value)
No single metric tells the full story. See the LTS:0RV2 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
BioArctic AB is a research-based biopharmaceutical company focusing on disease-modifying treatments and diagnostics for neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease, and ALS. Geographically, it derives a majority of its revenue from North America.
76GF Score
Get the complete analysis for LTS:0RV2
Total Assets is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
LTS:0RV2 has been successfully added to your 
